Incyte Corp (INCY)
66.25
-1.04 -1.55%
NASDAQ
Dec 14, 20:00
Delayed 2m
USD
View All Key Stats
INCY Key Stats
| Income Statement | |
| Revenue (TTM) | 1.798B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.53 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -109.20M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 94.49% |
| Profit Margin (Quarterly) | 6.49% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 14.10B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 7.867 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 7.820 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | 174.33M |
| Return on Equity (TTM) | Upgrade |
View All INCY News
INCY News
-
WireHeadlineTime (ET)
-
Yahoo12/14 07:59
-
Yahoo12/13 10:13
-
Yahoo12/13 08:06
-
Business Wire12/13 08:00
-
MT Newswires12/13 07:17
-
SA Breaking News12/13 06:51
-
PR Newswire12/13 06:45
-
Yahoo12/12 08:56
-
Yahoo12/10 15:45
-
Yahoo12/10 07:58
View All Events
INCY Events
| Date | Type | Description |
|---|---|---|
| 02/15/2019 10:00 EST | Misc | Incyte Corp Fourth Quarter Earnings Conference Call in 2018 |
| 02/15/2019 | Earnings | Incyte Corp Fourth Quarter Earnings in 2018 Release |
| 10/30/2018 08:00 EDT | Misc | Incyte Corp Third Quarter Earnings Conference Call in 2018 |
| 10/30/2018 | Earnings | Incyte Corp Third Quarter Earnings Results in 2018 |
| 07/31/2018 08:00 EDT | Misc | Incyte Corp Second Quarter Earnings Conference Call in 2018 |
| 07/31/2018 | Earnings | Incyte Corp Second Quarter Earnings Results in 2018 |
| 05/01/2018 08:00 EDT | Misc | Incyte Corp First Quarter Earnings Conference Call in 2018 |
| 05/01/2018 | Earnings | Incyte Corp First Quarter Earnings Results in 2018 |
| 05/01/2018 | Misc | Incyte Corp Annual General Meeting in 2017 |
| 02/15/2018 10:00 EST | Misc | Incyte Corp Fourth Quarter Earnings Conference Call in 2017 |
INCY Fundamentals
Income Statement View Statement
INCY Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
INCY One Page Reports
- One Page Report Download
INCY Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 66.25 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.incyte.com
- Investor Relations URL: http://www.incyte.com/ir/investor-overview.aspx
- HQ State/Province: Delaware
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Mid Cap/Growth
- Next Earnings Release: Feb. 15, 2019
- Last Earnings Release: Oct. 30, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Incyte Corp is a biopharmaceutical company. It discovers, develops and commercializes proprietary therapeutics. Its product JAKAFI, a JAK1 and JAK2 inhibitor is used for treatment of patients with intermediate or high risk myelofibrosis.
INCY Excel Add-In Codes
- Name: =YCI("INCY","name")
- Description: =YCI("INCY","description")
- Sector: =YCI("INCY","sector")
- Industry: =YCI("INCY","industry")
- Est. Current Fiscal Year End: =YCI("INCY","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other INCY Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- INCY Tweets Stocktwits
Advertisement
